Clofarabine versus fludarabine‐based reduced‐intensity conditioning regimen prior to allogeneic transplantation in adults with AML/MDS

Clofarabine versus fludarabine‐based reduced‐intensity conditioning regimen prior to allogeneic transplantation in adults with AML/MDS

We have retrospectively compared survivals between acute myeloid leukemia (AML)/myelodysplastic syndrome (MDS) patients who received either a clofarabine/busulfan (CloB2A2) or a fludarabine/busulfan (FB2A2) RIC regimen for allogeneic stem cell transplantation. Between 2009 and 2014, 355 allotranspla...

Full description

Bibliographic Details
Main Authors: Chevallier, Patrice, Labopin, Myriam, de La Tour, Regis Peffault, Lioure, Bruno, Bulabois, Claude‐Eric, Huynh, Anne, Blaise, Didier, Turlure, Pascal, Daguindau, Etienne, Maillard, Natacha, Yakoub‐Agha, Ibrahim, Guillerm, Gaelle, Delage, Jeremy, Contentin, Nathalie, Bay, Jacques‐Olivier, Beckerich, Florence, Bourhis, Jean‐Henri, Detrait, Marie, Vigouroux, Stéphane, François, Sylvie, Legrand, Faezeh, Guillaume, Thierry, Mohty, Mohamad
Format: Online
Language:English
Published: John Wiley and Sons Inc. 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5119961/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5119961/

Similar Items